<i>ZNF50</i> 3/ <i>Zpo2</i> drives aggressive breast cancer progression by down-regulation of GATA3 expression
Payam Shahi(University of California, San Francisco), Zena Werb(University of California, San Francisco), Devon A. Lawson(University of California, Irvine), Chih‐Yang Wang(University of California, San Francisco), Ying Yu(Wuhan University), Euan M. Slorach(Caribou Biosciences (United States)), Angela Lu(WinnMed), Ming-Derg Lai(National Cheng Kung University), Hugo González Velozo(University of California, San Francisco)
Cited by 48
Related Papers
A framework for advancing our understanding of cancer-associated fibroblasts
|Nature reviews. Cancer|2020|3.7k
The extracellular matrix: A dynamic niche in cancer progression
|The Journal of Cell Biology|2012|3k
Extracellular Matrix Degradation and Remodeling in Development and Disease
|Cold Spring Harbor Perspectives in Biology|2011|2.2k
Roles of the immune system in cancer: from tumor initiation to metastatic progression
|Genes & Development|2018|2.1k
Matrix metalloproteinases: effectors of development and normal physiology
|Genes & Development|2000|1.2k